Benitec Corp (BNTC) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Benitec Biopharma Inc. (BNTC) genlarni jimjit qilish orqali ilg'or gen terapiyasi usullarini ishlab chiqadi, uning daromadlari esa investitsiyalar va grantlarga asoslangan. Tarixiy narxlar dinamikasi shuni ko'rsatadiki, ushbu ko'rsatkich 0.00 hisoblanadi. Biznes istiqbollari BB-301 sinovlariga, ddRNAi tizimining xavfsizligiga va likvidlik rezervlariga bog'liq. Patent himoyasi va FDA orphan drug eksklyuzivligi kompaniyaning bozordagi mavqei barqarorligini ta'minlaydi.
Benitec Biopharma Inc. kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Benitec Biopharma Inc.|BNTC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi benitec.com|BNTC - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Benitec Biopharma Inc.|BNTC - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Benitec Biopharma|Shoshilinch likvidlik benitec.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:Benitec Biopharma Inc.
Ushbu koeffitsiyent bir yildan ortiq muddatli majburiyatlarni umumiy kapital bilan solishtirib, moliyaviy leveraj darajasini va aktivlarga tushgan qarz yukini aniqlaydi. Ushbu balansni optimallashtirish Benitec Biopharma Inc. uchun juda muhimdir, chunki barqaror moliyalashtirish qimmat biomaterial logistikasini ta'minlaydi va bu uzoq muddatli qarzning kapitalga nisbati grafigida yaqqol aks etgan.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRISPR Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|WGS: Uzoq muddatli qarzning o'z kapitaliga nisbati|RARE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Beam Tx (BEAM)|Uzoq muddatli qarzning o'z kapitaliga nisbati Sarepta Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TWST (twistbioscience.com)|Uzoq muddatli qarzning kapitalga nisbati TXG|Uzoq muddatli qarzdorlikning kapitalga nisbati Intellia Therapeutics Inc|Stoke - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati BLFS (BioLife)|Wave Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati mazetx.com|SION: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Prime Medicine Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati TSHA|QURE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MGTX|Uzoq muddatli qarzning o'z kapitaliga nisbati RGNX (regenxbio.com)|Uzoq muddatli qarzning kapitalga nisbati SLDB (Solid Biosciences)|Uzoq muddatli qarzdorlikning kapitalga nisbati Ocugen Inc (OCGN)|PACB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Design Corp|Rocket Pharmaceuticals (RCKT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati FDMT (4dmoleculartherapeutics.com)|LXEO (Lexeo Therapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|KRRO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati EDIT|Uzoq muddatli qarzning kapitalga nisbati Silence Therapeutics Corp (SLN)|Uzoq muddatli qarzning o'z kapitaliga nisbati ProQR Therapeutics PRQR|Uzoq muddatli qarzning kapitalga koeffitsiyenti CDXS|SGMO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Nautilus Biotechnology (NAUT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MGX: Uzoq muddatli qarzning kapitalga nisbati|Precision BioSciences Inc. (DTIL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati GBIO|BOLD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XCUR|Uzoq muddatli qarzdorlikning kapitalga nisbati imunon.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Phio Pharmaceuticals Corp. PHIO|MBIO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|TransCode - Uzoq muddatli qarzning kapitalga nisbati|Bionano Genomics, Inc. (BNGO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|APDN (Applied DNA Sciences, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BLUE - Uzoq muddatli qarzdorlikning kapitalga nisbati|IPA (ImmunoPrecise Antibodies Ltd) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati OMGA|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|regulusrx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Syros Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati TBIO (Telesis Bio Inc.)|TRACON - Uzoq muddatli qarzning kapitalga nisbati|Unity Biotechnology, Inc (UBX) - Uzoq muddatli qarzning o'z kapitaliga nisbati